Case Study: Mestag Therapeutics accelerates growth with iplicit

Growing biotech organisation Mestag Therapeutics accelerates growth with iplicit

Mestag Therapeutics, a pioneering biotech company, experienced phenomenal growth that quickly outpaced its entry-level Xero accounting system. They required a more sophisticated, cloud-based mid-market solution to gain better control over processes like purchase-to-pay and to enable project accounting. To meet this challenge, they chose to implement the award-winning cloud accounting software from iplicit.

By implementing iplicit, Mestag gained a comprehensive finance solution with real-time reporting and project accounting capabilities. This allowed project managers to self-serve their financial data, saving the finance team an estimated 2-3 days per month. The solution also eliminated the need for expensive in-house support or external consultancy. iplicit provided the scalable platform and powerful functionality Mestag needed to support its continued acceleration and growth.

Mestag Therapeutics

Eilidh Goodwin

Director of Finance